Human serum albumin (HSA) is the most abundant protein in blood serum.11 It has been widely investigated as a carrier for drug molecules.12,13 Albumin binding with anticancer agents can be accomplished using either covalent or non-covalent means.14 The resulting adducts typically benefit from improved pharmacokinetics, facilitated formulation, and tumour targeted drug delivery in vivo. The gene discussed is ALB; the disease is neoplasm.